Overnight Digest: Stocks to look out for on March 28

Overnight Digest: Stocks to look out for on March 28

Shohini Nath
/ Categories: Trending, Markets, DSIJ News

The stocks that are likely to witness significant movement on the bourses on March 28 are Lupin, Maruti Suzuki, Strides Pharma, Cadila Healthcare and Orient Electric.

Lupin: The company has received approval for its Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, from USFDA to market a generic version of Eli Lilly and Company’s Cialis Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.

Maruti Suzuki: The company has received approval for manufacturing of Vitara Brezza starting year 2022 at existing Toyota Kirloskar Motor (TKM) plant which will save investment in a new plant for the Company.

Strides Pharma: The company announced that its oral dosage plant in Singapore with manufacturing and research capabilities for tablets and hard gelatin capsules was approved by the US drug regulator.

Cadila Healthcare: Cadila Healthcare’s arm, Alidac Pharmaceuticals, a 100 per cent subsidiary of Cadila Healthcare gets one observation for Ahmedabad plant from USFDA.

Orient Electric: The company has received approval to consider setting-up new manufacturing facility for various products in south India, scout an appropriate location and firm up a project plan.


Previous Article Placement firms' stocks to benefit as recruitment activity picks up
Next Article Yash Papers gains on capex plan of Rs. 150 crore
Rate this article:
4.2

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR